<script> window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'UA-48293608-1'); </script>
Logo-bi
Bioimpacts. 2025;15: 30224 | Published on: 2024 Apr 15. doi: 10.34172/bi.2024.30224
PMID: 39963573        PMCID: PMC11830135

Review

Oil-in-water nanoemulsions for glaucoma treatment: An insight into the latest trends

Ankita Kishore 1 ORCID, Alok Kumar Mahor 1 * ORCID, Niraj Kumar Singh 2, Prem Prakash Singh 1, Priyanka Rathore 1 ORCID, Kuldeep Kumar Bansal 3 * ORCID

Cited by CrossRef: 3

1- Agarwal B, Chandapure S, Kakad A, More N, Panzade P, Rathi P, Patil P, Jagdale S. Brinzolamide microsponge-loaded in situ gel for sustained ocular delivery: design, characterization and in vivo evaluation. Naunyn-Schmiedeberg's Arch Pharmacol. 2026;399(10):15115 [Crossref]
2- Fatima R, Soni P, Sharma M, Prasher P, Kaverikana R, Mangalpady S, Sharifi-Rad J, Calina D. Fisetin as a chemoprotective and chemotherapeutic agent: mechanistic insights and future directions in cancer therapy. Med Oncol. 2025;42(4) [Crossref]
3- Kishore A, Mahor A, Gupta R, Singh P, Lodhi B, Rathore P, Rosenholm J, Bansal K, Rajamohan R. Acetazolamide‐Loaded Poly(δ‐Decalactone) Nanoemulsion for Topical Eye Delivery: Enhanced Corneal Permeation and Sustained Intraocular Pressure Reduction in Glaucoma Therapy. Journal of Nanotechnology. 2025;2025(1) [Crossref]
4- Sarkar T, Gogoi N, Jana B, Mazumder B. Formulation Advances in Posterior Segment Ocular Drug Delivery. Journal of Ocular Pharmacology and Therapeutics. 2025;41(3):101 [Crossref]
5- Bian X, Ma J, Liu Y, Feng Y, Liu Z, Zhang B, Huang B. Cyclosporine a in the treatment of dry eye disease: a narrative review. Front Ophthalmol. 2025;5 [Crossref]
6- Mohapatra D, Yang E, Corson T. Emulsion and Emulgel-Based Ophthalmic Drug Delivery Systems. Pharmaceutics. 2025;17(12):1504 [Crossref]
7- Lambert E, Nguyen C, Dunn S, Gary‐Bobo M, Lacombe J, Moser J, Zenhausern F, Durand J, Cunin F. Potential of Nanoparticle‐Based Phototherapies for Future Treatment of Uveal Melanoma. Advanced Science. 2026; [Crossref]

Poster

As a peer-reviewed international open-access journal, BioImpacts publishes articles on basic and translational aspects of pharmaceutical and biomedical sciences. 
Acceptance rate (2024): 19% 
Publication fee: Free of charge

Indexing/Abstracting Info
PubMed; PubMed Central; Scopus; Science Citation Index Expanded; Google Scholar;   SJR; Essential Science Indicators; Embase; EBSCOhost; CAS: DOAJ: SHERPA/RoMEO
Member of   
Follower of ICMJE
Permission: Creative Commons